PROCEDURE (IMPLANTATION) COST AND TOTAL HOSPITALIZATION COST OF PATIENTS SUBJECTED TO CARDIAC RHYTHM MANAGEMENT DEVICES IMPLANTATION- RESULTS FROM A SINGLE TERTIARY CENTRE
Author(s)
Fanourgiakis J1, Simantirakis E1, Kanoupakis E2, Chrysostomakis S1, Maniadakis N3, Kourlaba G4, Vardas P2
1University of Crete, Heraklion, Greece, 2University Hospital, Heraklion, Greece, 3National School of Public Health, Athens, Greece, 4National and Kapodistrian University of Athens School of Medicine, Athens, Greece
OBJECTIVES: The objective of the present study is to estimate the procedure (or implantation) cost, which includes: the human resources cost, the implant and the supplies cost and the total hospitalization cost which includes: the procedure cost, the hospitalization cost, the laboratory and imaging diagnostic examination cost and the indirect cost, in patients subjected to pacemaker (PM) and implantable cardioverter-defibrillator (ICD) implantation. METHODS: A single-centre, prospective study was conducted for one year’s period. In total, 464 consecutive patients were recruited (370 were subjected to PM implantation initial or replacement and 94 to ICD implantation initial or replacement). Resource data were assessed at patients’ enrolment in the study as well as during the procedure of implantation. Then, the components of the procedure cost and total hospitalization cost were calculated using the bottom-up approach. RESULTS: The mean (95% confidence interval) procedure cost of PM and ICD implantation (including the costs of devices, electrodes, other supplies, and personnel’s time) was calculated to be €1.803 (€ 1.758–€1.858) and € 13.521 (€ 13.153–€ 13.892), respectively. The mean total hospitalization cost (including procedure cost, hospitalization cost, cost of laboratory and imaging diagnostic examinations and the indirect cost attributed to productivity lost due to patient’s hospitalization) was €3.926 (€3.711–€4.167) for PM and €17.764 (€16.852–€18.692) for ICD. CONCLUSIONS: These data revealed that although these devices are associated with a relatively high upfront cost, the total implantation cost for the society is relatively low compared with other countries
Conference/Value in Health Info
2014-05, ISPOR 2014, Palais des Congres de Montreal
Value in Health, Vol. 17, No. 3 (May 2014)
Code
PCV99
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Cardiovascular Disorders